Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf052 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Marsida Teliti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Thyroid Nodule, Biopsy, Fine-Needle, Watchful Waiting, Thyroid Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP), Italian Ministry of University and Research, European Union-NextGenerationEU.
Abstract (Originalsprache)
Context
Thyroid nodules classified cytologically as low-risk indeterminate lesions (TIR3A) on fine-needle aspiration biopsy (FNAB) present a clinical challenge due to their uncertain malignancy risk.
Objective
This single-center study aimed to evaluate the natural history of TIR3A nodules.
Methods
FNABs performed between July 2017 and December 2019 were retrospectively retrieved and patients, with TIR3A nodules were evaluated at baseline and throughout a follow-up based on ultrasound (US) parameters and clinical data.
Results
The final study group encompassed 371 patients with an initial TIR3A cytological result. Among them, 102 were directed to surgery after the first endocrinological evaluation, and 269 were directed to conservative follow-up. Repeat FNAB was performed in 120 out of 269 and 13 further patients underwent surgery following FNAB repetition. The malignancy rate among TIR3A nodules was 16.5%, with most interventions being performed for reasons unrelated to the TIR3A result. Repeat FNAB provided a more definitive diagnosis in 40% of cases, with a 5% increase in malignancy risk. The remaining patients were monitored with clinical and US follow-up. Among all patients with TIR3A cytology managed conservatively (149 without FNAB repetition and 66 with at least one FNAB repetition), no significant changes in nodule size and/or US pattern were observed during a median follow-up of 3.3 years.
Conclusion
These findings suggest that active surveillance is a safe option for managing TIR3A nodules, particularly when no additional risk factors are present. The study highlights the role of repeat FNAB in reducing unnecessary surgeries and underscores the generally indolent nature of TIR3A nodules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
- Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.
- Istituti Clinici Scientifici Maugeri IRCCS, Department of General and Minimally Invasive Surgery, 27100 Pavia, Italy.
- Istituti Clinici Scientifici Maugeri IRCCS, Unit of Anatomic Pathology, 27100 Pavia, Italy.
ORCID-Profile: Mario Rotondi, Flavia Magri
Förderung
- National Recovery and Resilience Plan (NRRP)
- Italian Ministry of University and Research
- European Union-NextGenerationEU
- European Union–NextGenerationEU
Zitieren
APA
Teliti, M., Chytiris, S., Coperchini, F., Cerutti, M., Grillini, B., Gallo, M., Calì, B., Arpa, G., Rotondi, M., & Magri, F. (2025). Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf052
Vancouver
Teliti M, Chytiris S, Coperchini F, Cerutti M, Grillini B, Gallo M, et al. Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf052
BibTeX
@article{Teliti2025,
author = {Teliti, Marsida and Chytiris, Spyridon and Coperchini, Francesca and Cerutti, Matteo and Grillini, Beatrice and Gallo, Maria and Calì, Benedetto and Arpa, Giovanni and Rotondi, Mario and Magri, Flavia},
title = {Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf052}
}
EUVIMED